VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-01884
Package ID: USCOURTS-cofc-1_17-vv-01884
Petitioner: Tarmesha Brown
Filed: 2017-12-06
Decided: 2019-12-26
Vaccine: Tdap
Vaccination date: 2017-04-05
Condition: brachial neuritis
Outcome: compensated
Award amount USD: 80379

AI-assisted case summary:
Tarmesha Brown filed a petition for compensation under the National Vaccine Injury Compensation Program on December 6, 2017, alleging she suffered brachial neuritis after receiving a Tdap vaccine on April 5, 2017. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused the alleged injury. The parties subsequently filed a joint stipulation agreeing to settle the case. Chief Special Master Brian H. Corcoran reviewed the stipulation and adopted its terms as his decision. The stipulation stated that Tarmesha Brown received the Tdap vaccine in the United States on April 5, 2017, and alleged she suffered from brachial neuritis within the Table timeframe, with residual effects lasting more than six months. The respondent maintained their denial of causation. The parties agreed to settle the issues, and the stipulation outlined the compensation to be awarded. Chief Special Master Corcoran awarded Tarmesha Brown a lump sum of $80,379.22, payable by check to Petitioner. This amount was designated as compensation for all damages available under 42 U.S.C. § 300aa-15(a). The decision was issued on December 26, 2019. The stipulation also addressed the process for awarding reasonable attorneys' fees and costs, and confirmed that the compensation was not for items or services for which the Program is not primarily liable. Petitioner, represented by Andrew Donald Downing of Van Cott & Talamante, PLLC, and Respondent, represented by Christine Mary Becer of the U.S. Department of Justice, agreed to the terms. The stipulation included a release of claims by the petitioner against the United States and the Secretary of Health and Human Services related to the Tdap vaccination and alleged injury. The decision noted that it would be posted online, with a provision for the petitioner to request redaction of sensitive information. The public decision does not describe the specific onset of symptoms, clinical details of the brachial neuritis, diagnostic tests performed, or treatments received.

Theory of causation field:
Petitioner Tarmesha Brown filed a petition on December 6, 2017, alleging brachial neuritis caused by a Tdap vaccine received on April 5, 2017. The case was treated as a Table injury claim. Respondent denied causation. The parties entered into a joint stipulation to settle the case. The stipulation stated that the Tdap vaccine is on the Vaccine Injury Table and that petitioner alleged injury within the Table timeframe. The public text does not detail the specific mechanism of injury, expert testimony, or competing medical theories. The parties agreed to a settlement, and Chief Special Master Brian H. Corcoran adopted the stipulation, awarding Petitioner Tarmesha Brown $80,379.22 as compensation for all damages available under the Vaccine Act. The decision was issued on December 26, 2019. Attorneys for petitioner were Andrew Donald Downing and for respondent was Christine Mary Becer.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_17-vv-01884-0
Date issued/filed: 2019-12-26
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 11/05/2019) regarding 42 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (ypb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 17-1884V
UNPUBLISHED
TARMESHA BROWN,
Chief Special Master Corcoran
Petitioner,
Filed: November 5, 2019
v.
Special Processing Unit (SPU); Joint
SECRETARY OF HEALTH AND
Stipulation on Damages; Tetanus
HUMAN SERVICES,
Diphtheria acellular Pertussis (Tdap)
Vaccine; Brachial Neuritis
Respondent.
Andrew Donald Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for petitioner.
Christine Mary Becer, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Corcoran, Chief Special Master:
On December 6, 2017, Tarmesha Brown filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that she suffered extreme left arm pain ultimately
diagnosed as brachial neuritis after receiving the tetanus, diphtheria, acellular pertussis
(“Tdap”) vaccine on April 5, 2017. Petition at 1; Stipulation, filed Nov. 5, 2019, at ¶¶ 1-2,
4. Petitioner further alleges that Petitioner’s injury meets the definition of the Table
injury brachial neuritis or brachial neuritis which was caused in fact by the Tdap vaccine
she received, that she received the vaccination in the United States, and that neither
she nor any other party has filed a civil action or collected an award for her injury.
Petition at ¶¶ 3, 14-15; Stipulation at ¶¶ 3-5. “Respondent denies that the Tdap vaccine
caused petitioner to suffer from brachial neuritis or any other injury or her current
condition.” Stipulation at ¶ 6.
1 I intend to post this decision on the United States Court of Federal Claims' website. This means the
decision will be available to anyone with access to the internet. In accordance with Vaccine Rule
18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of
which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified
material fits within this definition, I will redact such material from public access. Because this unpublished
decision contains a reasoned explanation for the action in this case, I am required to post it on the United
States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. §
3501 note (2012) (Federal Management and Promotion of Electronic Government Services).
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 2 of 7
Nevertheless, on November 5, 2019, the parties filed the attached joint
stipulation, stating that a decision should be entered awarding compensation. I find the
stipulation reasonable and adopt it as my decision awarding damages, on the terms set
forth therein.
Pursuant to the terms stated in the attached Stipulation, the I award the following
compensation:
A lump sum of $80,379.22 in the form of a check payable to Petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under § 15(a). Id.
I approve the requested amount for Petitioner’s compensation. In the absence of
a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed
to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
TARMESHA BROWN, )
)
Petitioner, )
) No. 17-1884V
V. ) Chief Special Master Corcoran
) ECF
SECRETARY OF HEALTH AND )
HUMAN SERVICES, )
)
Respondent. )
STIPULATION
The parties hereby stipulate to the following matters:
I. Tarmesha Brown, petitioner, filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the "Vaccine
Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt
of a tetanus-diphtheria-acellular pertussis ("Tdap") vaccine, which vaccine is contained in the
Vaccine Injury Table (the "Table"), 42 C.F.R. § 100.3 (a).
2. Petitioner received the Tdap vaccine on April 5, 2017.
3. The vaccination was administered within the United States.
4. Petitioner alleges that she suffered from brachia! neuritis within the Table timeframe
after receiving the Tdap vaccine, and that she suffered from the residual effects for more than six
months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on her behalf as a result of her condition.
6. Respondent denies that the Tdap vaccine caused petitioner to suffer from brachia!

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 4 of 7
neuritis or any other injury or her current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry ofj udgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-2l(a)(l), the Secretary of Health and Human Services will issue
the following vaccine compensation payment:
A lump sum of $80,379.22 in the form of a check payable to petitioner. This
amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a).
9. As soon as practicable after the entry of judgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to
42 U.S.C. § 300aa-21(a)(l), and an application, the parties will submit to further proceedings
before the special master to award reasonable attorneys' fees and costs incurred in proceeding
upon this petition.
10. Petitioner and her attorney represent that compensation to be provided pursuant to
this Stipulation is not for any items or services for which the Program is not primarily liable
under 42 U.S.C. § 300aa-l 5(g), to the extent that payment has been made or can reasonably be
expected to be made under any State compensation programs, insurance policies, Federal or
State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C.
§ 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
2

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 5 of 7
11. Payment made pursuant to paragraph 8 of this Stipulation and any amounts awarded
pursuant to paragraph 9 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-
l 5(i), subject to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys' fees and litigation costs, and past unreimbursed expenses, the money provided
pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a
strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C.
§ 300aa-l 5(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in her
individual capacity, and on behalf of her heirs, executors, administrators, successors or assigns,
does forever irrevocably and unconditionally release, acquit and discharge the United States and
the Secretary of Health and Human Services from any and all actions or causes of action
(including agreements, judgments, claims, damages, loss of services, expenses and all demands
of whatever kind or nature) that have been brought, could have been brought, or could be timely
brought in the Court of Federal Claims, under the National Vaccine Injury Compensation
Program, 42 U.S.C. § 300aa-l O et seq., on account of, or in any way growing out of, any and all
known or nnknown, suspected or unsuspected personal injuries to or death of petitioner resulting
from, or alleged to have resulted from, the Tdap vaccination administered on April 5, 2017, as
alleged by petitioner in a petition for vaccine compensation filed on or about December 6, 2017,
in the United States Court of Federal Claims as petition No. 17-1884V.
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
3

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 6 of 7
15. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete conformity with the terms of this Stipulation, then the parties'
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties' respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the Tdap vaccine caused petitioner to have brachia!
neuritis or any other injury or her current condition.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner's
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
I
I
I
I
I
I
I
I
I
I
4

Case 1:17-vv-01884-UNJ Document 51 Filed 12/26/19 Page 7 of 7
Respectfully submitted,
PETITIONER:
BROWN
TARMESHA
A ITORNEY OF RECORD FOR AUTHORIZED REPRESENTATIVE
PETITIONER: OF THE AITORNEY GENERAL:
~
7_/
E.REEVES
Van Cott & Talamante, LL Deputy Director
3030 N. 3rd St., Suite 790 Torts Branch, Civil Division
Phoenix, AZ 85012 U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, DC 20044-0146
AUTHORIZED REPRESENTATIVE AITORNEYOFRECORDFOR
OF THE SECRETARY OF HEALTH RESPONDENT:
AND HUMAN SERVICES:
TAMARA OVERBY, M.~ CHRISTINE M. BECER
Acting Director, Division of Injury Ttjal Attorney
Compensation Programs Torts Branch, Civil Division
. Healthcare Systems Bureau. U.S. Department of Justice
U.S. Department of Health P.O.Box 146
and Human Services Benjamin Franklin Station
5600 Fishers Lane Washington, DC 20044-0146
Parklawn Building, Mail Stop 08Nl46B Tel: (202) 616-3665
Rockville, MD 20857
l /;q_
Dated: I/~
---------
5